- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin glargine U100
Total 4932 results
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Novo Nordisk A/SRecruitingObesity | Diabetes Mellitus, Type 2United States, Spain, Portugal, Italy, Greece, Romania, Slovakia, Czechia, South Africa, Ukraine
-
SanofiCompletedDiabetes Mellitus, Type 2Germany, Spain, Brazil, France, Ireland, Romania, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2Italy, Ireland, Spain, Greece, Finland, Romania, Brazil, United Kingdom, France, Switzerland
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Italy, Canada, Germany, Czechia
-
Novo Nordisk A/SCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Type 2 Diabetes Treated With InsulinUnited States, Germany, Mexico, Argentina, Puerto Rico, Italy, Spain, India
-
SanofiCompletedDiabetes Mellitus Type 2Germany
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Croatia, India, Poland, Spain, Serbia, Germany, Slovakia, Slovenia, Turkey, Hungary, Greece, Czechia, Bulgaria, South Africa, Romania, Bosnia and Herzegovina, Estonia, Portugal, Latvia, Lithuania, North Macedonia
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusCanada
-
SanofiTerminated
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
SanofiCompletedType I Diabetes MellitusBrazil
-
University Hospital TuebingenTerminatedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
SanofiActive, not recruiting
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
SanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
University of Split, School of MedicinePavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina... and other collaboratorsCompletedInsulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular FactorsDiabetes Mellitus, Type 2Croatia
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
Weill Cornell Medical College in QatarNovo Nordisk A/STerminated
-
King Faisal Specialist Hospital & Research CenterCompletedDiabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral NutritionSaudi Arabia
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
IRCCS San RaffaeleTerminatedType 2 Diabetes Mellitus | Peripheral Vascular DiseaseItaly
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany